Engineers at Washington University in St. Louis found a way to keep a cancerous tumor from growing by using nanoparticles of the main ingredient in common antacid tablets.
The research team, led by Avik Som, an MD/PhD student, and Samuel Achilefu, PhD, professor of radiology and of biochemistry & molecular biophysics in the School of Medicine and of biomedical engineering in the School of Engineering & Applied Science, in collaboration with two labs in the School of Engineering & Applied Science, used two novel methods to create nanoparticles from calcium carbonate that were injected intravenously into a mouse model to treat solid tumors. The compound changed the pH of the tumor environment, from acidic to more alkaline, and kept the cancer from growing.
With this work, researchers showed for the first time that they can modulate pH in solid tumors using intentionally designed nanoparticles. Results of the research were recently published online in Nanoscale.
“Cancer kills because of metastasis,” said Som, who is working on a doctorate in biomedical engineering in addition to a medical degree. “The pH of a tumor has been heavily correlated with metastasis. For a cancer cell to get out of the extracellular matrix, or the cells around it, one of the methods it uses is a decreased pH.”
The researchers set out to find new approaches to raise the pH of the tumor and do so only in the tumor environment. In water, the pH in calcium carbonate increases as high as 9. But when injected into the body, the team discovered that calcium carbonate only raises the pH to 7.4, the normal pH in the human body. However, working with calcium carbonate presented some challenges.
“Calcium carbonate doesn’t like to be small,” Som said. “Calcium carbonate crystals are normally 10 to 1,000 times bigger than an ideal nanoparticle for cancer therapy. On top of that, calcium carbonate in water will constantly try to grow, like stalactites and stalagmites in a cave.”
To solve this issue, Som worked with other researchers in the School of Engineering & Applied Science to create two unique solutions. Teaming up with researchers in the lab of Pratim Biswas, PhD, the Lucy & Stanley Lopata Professor and chair of the Department of Energy, Environmental & Chemical Engineering, they developed a method using polyethyleneglycol-based diffusion to synthesize 20- and 300-nanometer-sized calcium carbonate.
Working with Srikanth Singamaneni, PhD, assistant professor of materials science, they developed another method to create 100-nanometer-sized calcium carbonate by building on a method known as ethanol-assisted diffusion. By harnessing the complementary expertise of the different labs, the researchers developed a solvent made of albumin to keep the calcium carbonate nanoparticles from growing, allowing them to be injected into the body intravenously.
Commonly, nanoparticles have been made with gold and silver. However, neither are present in the human body, and there are concerns about them accumulating in the body.
“Calcium and carbonate are both found heavily in the body, and they are generally non-toxic,” Som said. “When calcium carbonate dissolves, the carbonate becomes carbon dioxide and is released through the lungs, and calcium is often incorporated into the bones.”
Som and the team injected the calcium carbonate nanoparticles into the mouse fibrosarcoma model daily, which kept the tumor from growing. However, when they stopped injecting the nanoparticles, it started growing again.
Going forward, the researchers plan to determine the optimal dose to prevent metastasis, improve targeting to tumors and determine if it could be used with chemotherapy drugs.
Read more: Novel nanoparticle made of common mineral may help keep tumor growth at bay
The Latest on: Cancerous tumor
[google_news title=”” keyword=”Cancerous tumor” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Cancerous tumor
- Harvard Health Publishing Q&a: Squamous Cell Skin Canceron May 10, 2024 at 4:44 am
What is the cause and some treatment options for Squamous cell carcinoma? Answered by Dr. Howard E. Lewine M.D. Chief Medical Editor, Harvard Health Publishing · 40 years of experience · USA Squamous ...
- Ask Amy: I’ve accepted my incurable cancer diagnosis, but I don’t want it to define meon May 10, 2024 at 4:43 am
A reader tells Amy that he was diagnosed with state 4 prostate cancer. It’s not curable. He’s accepted it but keeping it mostly a secret. He doesn’t want cancer to define him. Is ...
- Ask Amy: Man doesn’t want cancer to define himon May 10, 2024 at 4:11 am
Dear Amy: I’m a 57-year-old man. I was recently diagnosed with Stage 4 prostate cancer. I am obviously not overjoyed, but I am totally accepting of this news. Living with — not dying of — cancer means ...
- Pfizer to Settle 10K Lawsuits Over Drug Linked to Cancer, Costing Company Millionson May 10, 2024 at 3:49 am
Big Pharma giant Pfizer confirmed on Wednesday that it will settle more than 10,000 lawsuits over allegations that the company ...
- Glimmer Of Hope Foundation and the Pittsburgh Pirates reminding breast cancer patients they're not aloneon May 10, 2024 at 3:05 am
Dr. Christie Hilton at Allegheny General Hospital knows a lot about breast cancer and how it can impact women both at home and at work.
- A blood test to help detect lung cancer? New test offered at OSF Healthcare part of trend in medicineon May 10, 2024 at 3:00 am
Julie Harris had never been tested for lung cancer. A low-dose CT scan, the only recommended screening for adults at risk of developing lung cancer, was not something she’d ever found time to do. But ...
- Here's how you can help out Bakes for Breast Cancer with POP Culture: Fall River Eatson May 10, 2024 at 1:11 am
Fall River Eats takes a look at how POP Culture cake pops is donating to Bakes for Breast Cancer, and how you can help out.
- Billionaire-Backed Cancer Researcher Claire Mazumdar Finds Entrepreneurial Nicheon May 10, 2024 at 12:04 am
Mazumdar runs Boston-based Bicara Therapeutics, which is developing a novel, dual-action drug to treat head and neck cancers.
- Ask Amy: Man chooses to keep cancer diagnosis private. ‘I don’t want people to treat me differently’on May 10, 2024 at 12:04 am
Oftentimes it is strangers who can step up with great understanding and pointed advice and support. The American Cancer Society’s cancer survivor network hosts active, informative, and supportive ...
- Nearly half of cancer patients have medical debt, despite most being insuredon May 9, 2024 at 1:15 pm
Overall, 47% of patients reported medical debt related to their cancer treatment, with half carrying debt that exceeded $5,000. More than two-thirds carried their debt for more than a year; about a ...
via Bing News